Alzheimer's disease risk factor complement receptor 1 is associated with depression
Gillian Hamilton1, Kathryn L Evans, Donald J Macintyre
1Medical Genetics, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, UK. g.hamilton@ed.ac.uk
Neuroscience Letters
|January 17, 2012
Summary
Genetic variations in the complement receptor 1 (CR1) gene are linked to Alzheimer's disease risk. Specific CR1 variants are associated with major recurrent depression in females, suggesting a shared genetic basis.
Area of Science:
- Genetics
- Neuroscience
- Psychiatry
Background:
- Genome-wide association studies identified variations in the complement receptor 1 (CR1) gene as a risk factor for Alzheimer's disease.
- The CR1 gene plays a role in immune regulation and complement system activation.
Purpose of the Study:
- To investigate the association between specific CR1 gene variants and major recurrent depression in females.
- To explore potential shared genetic underpinnings between Alzheimer's disease and major recurrent depression.
Main Methods:
- Analysis of a population-based cohort from the Generation Scotland: Scottish Family Health Study.
- Genotyping of CR1 variants rs6656401 and rs3818361.
- Statistical association testing between CR1 variants and major recurrent depression in females.
Main Results:
- Two CR1 variants, rs6656401 and rs3818361, were found to be significantly associated with major recurrent depression in females.
- The findings suggest a potential genetic link between CR1 and depression susceptibility in women.
Conclusions:
- CR1 gene variants associated with Alzheimer's disease risk are also linked to major recurrent depression in females.
- These findings highlight the CR1 gene as a potential shared genetic factor in neurodegenerative and psychiatric disorders.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...